NCT02380352View on ClinicalTrials.gov

Short-course Antimicrobial Therapy for Paediatric Respiratory Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

281

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

April 30, 2020

Conditions
Community-acquired Pneumonia
Interventions
DRUG

Amoxicillin

DRUG

Placebo

Experimental arm must receive 5 days placebo after 5 days amoxicillin to preserve blinding.

Trial Locations (2)

L8S 4K1

McMaster Children's Hospital, Hamilton

Unknown

Children's Hospital of Eastern Ontario, Ottawa

All Listed Sponsors
collaborator

Children's Hospital of Eastern Ontario

OTHER

lead

Hamilton Health Sciences Corporation

OTHER

NCT02380352 - Short-course Antimicrobial Therapy for Paediatric Respiratory Infections | Biotech Hunter | Biotech Hunter